Search - tctmd.com

Displaying 1 - 20 of 135

Sort: Relevancy | Date

News Daily News

Evolocumab Gains Expanded Indication for Primary Prevention

Michael O'Riordan

August 26, 2025

News Daily News

Some Ups, Some Downs in Proposed CMS Reimbursement for 2026, Cardiologists Say

L.A. McKeown

July 22, 2025

News Daily News

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

L.A. McKeown

July 15, 2025

News Daily News

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

Michael O'Riordan

June 25, 2025

News Daily News

Funding for Women’s Health Initiative Imperiled, but Appears Secure for Now

Yael L. Maxwell

April 25, 2025

News Daily News

Knowledge of Genetic Risk for CAD Bolsters Prevention, Reduces MACE

Caitlin E. Cox

April 23, 2025

News Daily News

The ‘Smoker’s Paradox’ Takes a New Hit From Long-term Analysis

Yael L. Maxwell

March 24, 2025

News Daily News

Elderly ASCVD Patients Benefit From Aggressive LDL-Lowering With Evolocumab

Michael O'Riordan

February 05, 2025

News Daily News

Lost Chances: Medicare Analysis Says Preamputation Vascular Care Eludes Many

L.A. McKeown

January 16, 2025

News Daily News

Statins Are Cost-effective in the Elderly

Michael O'Riordan

September 11, 2024

News Daily News

Amputation Risks Higher After Revascularization in Younger vs Older PAD Patients

L.A. McKeown

July 24, 2024

News Daily News

AHA Kicks Off Funding for Women’s Heart Health Amid Sex Gaps

Caitlin E. Cox

July 01, 2024

News Daily News

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

L.A. McKeown

May 17, 2024

News Daily News

Lp(a) Linked to Higher ASCVD Risks in Diverse Patient Groups

Michael O'Riordan

April 17, 2024

News Daily News

High Lp(a) Levels Harmful in Patients With and Without ASCVD

Michael O'Riordan

February 27, 2024

News Daily News

Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

Michael O'Riordan

February 08, 2024

News Daily News

Less Is More: Lp(a) Much More Atherogenic Than LDL

Michael O'Riordan

January 16, 2024

News Daily News

Millions of Lives Lost to CVD Each Year: ‘Almanac’ Updates Global Burden

Caitlin E. Cox

December 12, 2023

News Daily News

Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes

Michael O'Riordan

December 08, 2023

News Daily News

Rosuvastatin, Atorvastatin: Similar Efficacy in LODESTAR, Some Differing Signals

Yael L. Maxwell

October 19, 2023

Advertisement

Evolocumab Gains Expanded Indication for Primary Prevention

Some Ups, Some Downs in Proposed CMS Reimbursement for 2026, Cardiologists Say

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

Funding for Women’s Health Initiative Imperiled, but Appears Secure for Now

Knowledge of Genetic Risk for CAD Bolsters Prevention, Reduces MACE

The ‘Smoker’s Paradox’ Takes a New Hit From Long-term Analysis

Elderly ASCVD Patients Benefit From Aggressive LDL-Lowering With Evolocumab

Lost Chances: Medicare Analysis Says Preamputation Vascular Care Eludes Many

Statins Are Cost-effective in the Elderly

Amputation Risks Higher After Revascularization in Younger vs Older PAD Patients

AHA Kicks Off Funding for Women’s Heart Health Amid Sex Gaps

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

Lp(a) Linked to Higher ASCVD Risks in Diverse Patient Groups

High Lp(a) Levels Harmful in Patients With and Without ASCVD

Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

Less Is More: Lp(a) Much More Atherogenic Than LDL

Millions of Lives Lost to CVD Each Year: ‘Almanac’ Updates Global Burden

Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes

Rosuvastatin, Atorvastatin: Similar Efficacy in LODESTAR, Some Differing Signals

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content